Strides Pharma, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across key global markets. Founded in 1990, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. Strides Pharma focuses on a diverse range of therapeutic areas, including oncology, anti-infectives, and controlled substances, setting itself apart with a commitment to innovation and quality. With a robust portfolio of core products and a strong emphasis on research and development, Strides Pharma has achieved significant milestones, including numerous product approvals and partnerships that enhance its market position. The company is recognised for its dedication to delivering affordable healthcare solutions, making it a trusted name in the pharmaceutical landscape.
How does Strides Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Strides Pharma, Inc.'s score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Strides Pharma, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Companies are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. Strides Pharma may be involved in such efforts, but specific commitments or achievements have not been disclosed.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Strides Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.